Diabetes Drug Options
Standard medical treatment protocols for Diabetes 2 always mention "lifestyle changes" and then quickly proceed to medication options. While diet is sometimes mentioned , the critical, decisive importance of diet revision and exercise is not emphasized and in practice, diet revision is often neglected in favor of drug treatments.
Drug treatments of Diabetes 2 present some problems. The main problem is the false belief that a drug or combination of drugs can rescue an individual from a disease-causing lifestyle. While there are benefits to be had with the newer medications, a diabetic should learn expert self-management skills and exercise all the therapeutic and preventative options available before considering medications.
The most negative aspect of medication is that a drug prescription may be taken to mean that the patient is passive, dependent and has been excused from making all the important changes that will preserve body parts and ultimately save his or her life. If the drug is taken as permission to postpone or forego the vitally important changes in food choices, eating behaviors and exercise, then the prescription has done a great disservice.
;Most overweight patients with early DB2 have too much insulin so that the sulphonylureas may cause hypoglycemia. A drug that would restore the proper release and function of insulin sounds like a good idea. Other hormones besides insulin regulate blood sugar. Glucagon is another hormone made by the pancreas that causes cells to release sugar into the bloodstream. By blocking glucagon, blood glucose levels can be lowered. Drugs that inhibit the action of two other hormones that increase blood sugar levels, glucocorticoids and growth hormone, could have a similar effect.
A single, ideal drug with long-term benefits may never be found since there are likely to be many different mechanisms behind the failure of glucose regulation. Thus, drug combinations are becoming more popular, although reassuring evidence of long-term efficacy and benefit is still scarce. The dietary and environmental determinants of glucose-regulation failure are likely to be multiple. Drug studies tend to produce a distorted view of diabetics and are seldom compared to successful attempts to control the disease with diet revision, exercise and weight loss. Medical treatment plans for DB2 give lip service to the “life-style changes” that are required to control this disease. Medical treatment plans underestimate the intensity of compulsive eating experienced by diabetics.
Drugs to Lower Blood Sugar
Our perspective is that the drug treatment of diabetes is lacking in
convincing long-term efficacy and there are an number of important concerns
about side effects and long-term adverse effects. Oral medications should not be
considered as primary treatment. MDs tend to be drug prescribers and do not
teach self-management skills.
Medical treatment plans often give lip service to the life-style changes that are required to control this disease and seldom are realistic about the difficulties encountered by anyone who attempts major diet change. Medical treatment plans also are unaware of or underestimate the intensity of habitual eating patterns and the compulsive eating aspect of the diabetic experience. Drugs are prescribed as soon as a patient fails to achieve diet control and often provide a false of security that the problem is being handled. Drug-taking patients continue to eat too much of the wrong food and exercise too little.
Metformin (Glucophage) remains the “first drug of choice” for diabetics who do not control their blood sugar with diet revision and exercise. The U.K. Prospective Diabetes Study (UKPDS) demonstrated that metformin is as effective as sulfonylureas in obese subjects and is associated with less weight gain, fewer hypoglycemic episodes, and better cardiovascular outcomes. In addition, they found that Metformin was equally effective in normal weight subjects.
Pharmaceutics companies have been busy developing new drugs for the increasing populations of diabetics worldwide. A variety of drug targets have been selected. After a flood of studies and some encouraging news, the old drugs - metformin and the sulfonylureas, appear to be as effective.
Tucker summarized a review of the new drugs:" There are currently 11 classes of approved glucose-lowering medications. Metformin has a long-standing evidence base for efficacy and safety, is inexpensive, and is regarded by most as the primary first-line treatment for type 2 diabetes. When metformin fails to achieve or maintain glycemic goals, another agent needs to be added. However, there is no consensus or sufficient evidence supporting the use of one second-line agent over another. And in the past decade, the mix of secondary agents used in the treatment of diabetes has changed significantly, with increasing use of newer glucose-lowering agents such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) agonists in place of older and less expensive drugs such as sulfonylureas, resulting in a dramatic rise in the cost of diabetes medications and management. However, the long-term clinical benefit of this shift is uncertain...Average medication costs per month were $81.75 for metformin, $54.85 for sulfonylurea, $232.84 for DPP-4 inhibitor, $325.97 for GLP-1 agonist, and $245.70 for insulin.
Take Drugs or Remove Cause.
We realize that the task of changing and then controlling eating behaviors long-term is not an easy one. The task is to realistically assess your own eating behaviors, understand what has to change and then recruit the necessary resources to make this change.According to the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Public Health Service. "Oral diabetes medicines, or oral hypoglycemics, can lower blood glucose in people who have diabetes, but are able to make some insulin. They are an option if diet and exercise don't work. Oral diabetes medications are not insulin and are not a substitute for diet and exercise. Although experts don't understand exactly how each oral medicine works, they know that they increase insulin production and affect how insulin lowers blood glucose. These medications are most effective in people who developed diabetes after age 40, have had diabetes less than 5 years, are normal weight, and have never received insulin or have taken only 40 units or less of insulin a day. Pregnant and nursing women shouldn't take oral medications because their effect on the fetus and newborn is unknown, and because insulin provides better control of diabetes during pregnancy.
There is also some question about whether oral diabetes medications increase the risk of a heart attack. Experts disagree on this point and many people with noninsulin-dependent diabetes use oral medicines safely and effectively. The Food and Drug Administration (FDA), the agency of the Federal Government that approves medications for use in this country, requires that oral diabetes medicines carry a warning concerning the increased risk of heart attack. Whether someone uses a medication depends on its benefits and risks, something a doctor can help the patient decide.
The purpose of oral medications is to lower blood glucose. Therefore, the person taking them must eat regular meals and engage in only light to moderate exercise, to prevent blood glucose from dipping too low. Medications taken for other health problems, including illness, also can lower blood sugar and may react with the diabetes medicine. Therefore, a doctor needs to know all the medications a person is taking to prevent a harmful interaction. Lowering blood sugar too much can cause hypoglycemia with symptoms such as headache, weakness, shakiness, and if the condition is severe enough, collapse. "
Most studies of drug-treated diabetes patients show a progression of the
disease on medications, often with failure within 5 years. There are concerns
about side effects and long-term adverse effects. Unfortunately taking the older
oral hypoglycemic medications may not reduce the long-term complications of
diabetes.Newer medications may be promising but long-term outcomes will
not be known for many years. New problems continue surface with drug use.